• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.社区人群中 N 端脑利钠肽前体浓度与心力衰竭绝对风险的性别和种族差异。
JAMA Cardiol. 2022 Jun 1;7(6):623-631. doi: 10.1001/jamacardio.2022.0680.
2
Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.N 端脑利钠肽前体水平长期变化与心力衰竭和死亡的相关性研究。
JAMA Cardiol. 2023 Mar 1;8(3):222-230. doi: 10.1001/jamacardio.2022.5309.
3
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.N端前脑钠肽与有无肥胖个体的心力衰竭风险:社区动脉粥样硬化风险(ARIC)研究
Circulation. 2016 Feb 16;133(7):631-8. doi: 10.1161/CIRCULATIONAHA.115.017298. Epub 2016 Jan 8.
4
Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.REGARDS 研究中 NT-proBNP 与新发心力衰竭风险的关联存在种族差异。
JCI Insight. 2019 Jun 4;5(13):129979. doi: 10.1172/jci.insight.129979.
5
N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.N 端脑利钠肽前体、左心室质量与心力衰竭事件:动脉粥样硬化的多种族研究。
Circ Heart Fail. 2012 Nov;5(6):727-34. doi: 10.1161/CIRCHEARTFAILURE.112.968701. Epub 2012 Oct 2.
6
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.高敏肌钙蛋白T和N末端B型利钠肽原(NT-proBNP)与慢性肾脏病患者发生心力衰竭的风险:慢性肾功能不全队列(CRIC)研究
J Am Soc Nephrol. 2015 Apr;26(4):946-56. doi: 10.1681/ASN.2014010108. Epub 2014 Oct 2.
7
N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study.N 末端 pro-B 型利钠肽预测室性心律失常:来自 SMASH 研究的数据。
Clin Cardiol. 2023 Aug;46(8):989-996. doi: 10.1002/clc.24074. Epub 2023 Jul 3.
8
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
9
Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.种族和性别均不影响氨基末端脑钠肽前体检测在呼吸困难患者中的效用:急诊科呼吸困难的脑钠肽前体调查(PRIDE)子研究。
J Card Fail. 2006 Aug;12(6):452-7. doi: 10.1016/j.cardfail.2006.04.005.
10
N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.前激素脑型利钠肽(NT-proBNP)的N端片段、心血管事件与稳定型冠心病患者的死亡率
JAMA. 2007 Jan 10;297(2):169-76. doi: 10.1001/jama.297.2.169.

引用本文的文献

1
Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex.B型利钠肽与死亡率及住院结局的关联因性别而异。
JACC Adv. 2025 Jul 24;4(8):101999. doi: 10.1016/j.jacadv.2025.101999.
2
Dissecting Sex-Specific Pathology in K18-hACE2 Transgenic Mice Infected With Different SARS-CoV-2 Variants.剖析感染不同SARS-CoV-2变体的K18-hACE2转基因小鼠的性别特异性病理学
J Med Virol. 2025 Jul;97(7):e70506. doi: 10.1002/jmv.70506.
3
Use of NT-proBNP for the screening, diagnosis and risk-stratification of left ventricular dysfunction.N末端B型利钠肽原在左心室功能障碍筛查、诊断及风险分层中的应用。
Diabetes Obes Metab. 2025 Sep;27 Suppl 8(Suppl 8):7-14. doi: 10.1111/dom.16388. Epub 2025 Apr 9.
4
Sex differences in diagnosis and treatment of heart failure: toward precision medicine.心力衰竭诊断与治疗中的性别差异:迈向精准医学
Korean J Intern Med. 2025 Mar;40(2):196-207. doi: 10.3904/kjim.2024.338. Epub 2025 Mar 1.
5
Does Adiponectin Inform Cardiovascular Risk in Older Adults?: The ARIC Study.脂联素能否提示老年人的心血管风险?:动脉粥样硬化风险社区研究(ARIC研究)
JACC Adv. 2025 Mar;4(3):101625. doi: 10.1016/j.jacadv.2025.101625. Epub 2025 Feb 20.
6
Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population.心力衰竭筛查:在普通人群中检测风险升高的生物标志物。
Curr Heart Fail Rep. 2024 Dec;21(6):591-603. doi: 10.1007/s11897-024-00686-6. Epub 2024 Sep 17.
7
Sex-based Differences in Heart Failure Biomarkers.基于性别的心力衰竭生物标志物差异。
Curr Heart Fail Rep. 2024 Aug;21(4):379-388. doi: 10.1007/s11897-024-00665-x. Epub 2024 May 20.
8
Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics.射血分数保留的心力衰竭中NT-脑钠肽前体的持续谜团:蛋白质组学的见解
Circ Heart Fail. 2024 Feb;17(2):e011428. doi: 10.1161/CIRCHEARTFAILURE.123.011428. Epub 2024 Feb 1.
9
Sizing and mending of appendicular muscle mass for hydration during the 12-lead electrocardiogram: True incidence of sarcopenia in heart failure.四肢肌肉量的大小和修补用于 12 导联心电图期间的水化:心力衰竭时的真正肌少症发生率。
J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):575-586. doi: 10.1002/jcsm.13423. Epub 2024 Jan 26.
10
Prehospital Targeting of 1-Year Mortality in Acute Chest Pain by Cardiac Biomarkers.通过心脏生物标志物对急性胸痛患者1年死亡率进行院前靶向治疗。
Diagnostics (Basel). 2023 Dec 16;13(24):3681. doi: 10.3390/diagnostics13243681.

社区人群中 N 端脑利钠肽前体浓度与心力衰竭绝对风险的性别和种族差异。

Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.

机构信息

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Division of Medicine, Akershus University Hospital and University of Oslo, Oslo, Norway.

出版信息

JAMA Cardiol. 2022 Jun 1;7(6):623-631. doi: 10.1001/jamacardio.2022.0680.

DOI:10.1001/jamacardio.2022.0680
PMID:35476049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9047747/
Abstract

IMPORTANCE

Sex- and race-based differences in N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations are poorly understood. Clinical decisions are often informed by absolute-as opposed to relative-risk, but absolute risk of incident heart failure (HF) associated with NT-proBNP concentration across these important demographic categories is unclear.

OBJECTIVE

To determine whether physiologic determinants of NT-proBNP concentrations account for sex and race differences, and to more uniformly predict HF risk using NT-proBNP in these demographic subgroups.

DESIGN, SETTING, AND PARTICIPANTS: In the longitudinal Atherosclerosis Risk in Communities epidemiologic prospective community-based cohort study, the association of NT-proBNP concentration with relative and absolute risk of HF by sex- and race-based categories was assessed at study visit 2 (1990-1992) and study visit 5 (2011-2013) using Cox and Poisson regression. These data were analyzed from June 2018 to October 2021. The contribution of clinical, anthropometric, echocardiographic, and laboratory parameters to sex- and race-based differences in NT-proBNP concentration was assessed at visit 5 using linear regression. Participants included were free of HF in midlife (visit 2; a total of 12 750 participants) and late life (visit 5; a total of 5191 participants).

EXPOSURES

NT-proBNP concentration.

MAIN OUTCOMES AND MEASURES

Incident HF or death.

RESULTS

Among the 5191 HF-free participants at visit 5, the mean (SD) age was 76.0 (5.2) years, 2104 (41%) were male, 1043 (20%) were Black, and the median (IQR) NT-proBNP concentration was 124 (64-239) pg/. In both midlife and late life, NT-proBNP concentration was lowest in Black men (median [IQR] concentration: visit 2, 30 [14-67] pg/mL; visit 5, 74 [34-153] pg/mL) and highest in White women (median [IQR] concentration: visit 2, 70 [42-111] pg/mL; visit, 5, 154 [82-268] pg/mL). Sex and race differences in NT-proBNP concentration persisted after accounting for age, income, education, area deprivation index, cardiovascular diseases, left ventricular structure (LV), LV function, LV wall stress, weight and fat mass, and estimated glomerular filtration rate. Substantial differences in the absolute risk of incident HF or death existed across the sex- and race-based categories at any NT-proBNP concentration (eg, 7-fold [rate ratio, 6.7; 95% CI, 4.6-9.9] and 3-fold [rate ratio, 2.7; 95% CI, 1.7-4.1] difference at visit 2 and visit 5, respectively, at guideline-recommended thresholds) with higher risk consistently observed among Black men and lower risk in White women. Results were replicated in a cohort of participants from the Cardiovascular Health Study.

CONCLUSIONS AND RELEVANCE

In this study, sex- and race-based differences in NT-proBNP persisted after accounting for known physiologic determinants. Absolute risk associated with a given value of NT-proBNP varied substantially by sex and race. Consideration of NT-proBNP values in the context of sex and race allows for more uniform prediction of absolute risk across important demographic subgroups.

摘要

重要性

N-末端 B 型利钠肽前体(NT-proBNP)浓度的性别和种族差异了解甚少。临床决策通常是基于绝对风险,而不是相对风险,但与 NT-proBNP 浓度相关的心力衰竭(HF)事件的绝对风险在这些重要的人口统计学类别中尚不清楚。

目的

确定 NT-proBNP 浓度的生理决定因素是否解释了性别和种族差异,并使用 NT-proBNP 更均匀地预测这些人口统计学亚组的 HF 风险。

设计、地点和参与者:在社区队列前瞻性社区为基础的 Atherosclerosis Risk in Communities 流行病学研究中,在研究访问 2(1990-1992 年)和研究访问 5(2011-2013 年)中,使用 Cox 和泊松回归评估 NT-proBNP 浓度与性别和种族分类的 HF 相对和绝对风险的相关性。这些数据是在 2018 年 6 月至 2021 年 10 月之间进行分析的。使用线性回归评估临床、人体测量、超声心动图和实验室参数对 NT-proBNP 浓度的性别和种族差异的贡献。参与者包括在中年(访问 2;共 12750 名参与者)和晚年(访问 5;共 5191 名参与者)无 HF 的人群。

暴露

NT-proBNP 浓度。

主要结果和措施

HF 或死亡的发生率。

结果

在 5191 名 HF 无患者中,中位(SD)年龄为 76.0(5.2)岁,2104 名(41%)为男性,1043 名(20%)为黑人,中位(IQR)NT-proBNP 浓度为 124(64-239)pg/ml。在中年和晚年,黑人男性的 NT-proBNP 浓度最低(中位数[IQR]浓度:访问 2,30[14-67]pg/ml;访问 5,74[34-153]pg/ml),白人女性的浓度最高(中位数[IQR]浓度:访问 2,70[42-111]pg/ml;访问 5,154[82-268]pg/ml)。在考虑年龄、收入、教育程度、区域贫困指数、心血管疾病、左心室结构(LV)、LV 功能、LV 壁应力、体重和脂肪量以及估计肾小球滤过率后,NT-proBNP 浓度的性别和种族差异仍然存在。在任何 NT-proBNP 浓度下,HF 或死亡发生率的绝对风险在性别和种族分类中都存在显著差异(例如,在访问 2 和访问 5 时,分别为 7 倍[率比,6.7;95%CI,4.6-9.9]和 3 倍[率比,2.7;95%CI,1.7-4.1]),黑人男性的风险更高,白人女性的风险更低。在心血管健康研究的参与者队列中得到了复制。

结论和相关性

在这项研究中,在考虑到已知生理决定因素后,NT-proBNP 的性别和种族差异仍然存在。与特定 NT-proBNP 值相关的绝对风险在性别和种族之间有很大差异。考虑 NT-proBNP 值在性别和种族背景下,可以更均匀地预测重要人口统计学亚组的绝对风险。